Articles with public access mandates - Martin GlennieLearn more
Not available anywhere: 2
Intimate cell conjugate formation and exchange of membrane lipids precede apoptosis induction in target cells during antibody-dependent, granulocyte-mediated cytotoxicity
H Horner, C Frank, C Dechant, R Repp, M Glennie, M Herrmann, ...
The Journal of Immunology 179 (1), 337-345, 2007
Mandates: German Research Foundation
Development and characterization of monoclonal antibodies specific for mouse and human Fcγ receptors
AL Tutt, S James, SA Laversin, TRW Tipton, M Ashton-Key, RR French, ...
The Journal of Immunology 195 (11), 5503-5516, 2015
Mandates: Cancer Research UK, UK Medical Research Council
Available somewhere: 60
Guidelines for the welfare and use of animals in cancer research
P Workman, EO Aboagye, F Balkwill, A Balmain, G Bruder, DJ Chaplin, ...
British journal of cancer 102 (11), 1555-1577, 2010
Mandates: Cancer Research UK
Agonistic CD40 antibodies and cancer therapy
RH Vonderheide, MJ Glennie
Clinical Cancer Research 19 (5), 1035-1043, 2013
Mandates: US National Institutes of Health, Cancer Research UK
Antigenic modulation limits the efficacy of anti-CD20 antibodies: implications for antibody selection
SA Beers, RR French, HTC Chan, SH Lim, TC Jarrett, RM Vidal, ...
Blood, The Journal of the American Society of Hematology 115 (25), 5191-5201, 2010
Mandates: Cancer Research UK
Novel type II anti-CD20 monoclonal antibody (GA101) evokes homotypic adhesion and actin-dependent, lysosome-mediated cell death in B-cell malignancies
W Alduaij, A Ivanov, J Honeychurch, EJ Cheadle, S Potluri, SH Lim, ...
Blood, The Journal of the American Society of Hematology 117 (17), 4519-4529, 2011
Mandates: Cancer Research UK
Fc gamma receptor IIb on target B cells promotes rituximab internalization and reduces clinical efficacy
SH Lim, AT Vaughan, M Ashton-Key, EL Williams, SV Dixon, HTC Chan, ...
Blood, The Journal of the American Society of Hematology 118 (9), 2530-2540, 2011
Mandates: Cancer Research UK
CD20 as a target for therapeutic type I and II monoclonal antibodies
SA Beers, CHT Chan, RR French, MS Cragg, MJ Glennie
Seminars in hematology 47 (2), 107-114, 2010
Mandates: Cancer Research UK
Interaction with FcγRIIB is critical for the agonistic activity of anti-CD40 monoclonal antibody
AL White, HT Chan, A Roghanian, RR French, CI Mockridge, AL Tutt, ...
The Journal of Immunology 187 (4), 1754-1763, 2011
Mandates: Cancer Research UK
Monoclonal antibodies directed to CD20 and HLA-DR can elicit homotypic adhesion followed by lysosome-mediated cell death in human lymphoma and leukemia cells
A Ivanov, SA Beers, CA Walshe, J Honeychurch, W Alduaij, KL Cox, ...
The Journal of clinical investigation 119 (8), 2143-2159, 2009
Mandates: Cancer Research UK
Conformation of the human immunoglobulin G2 hinge imparts superagonistic properties to immunostimulatory anticancer antibodies
AL White, HTC Chan, RR French, J Willoughby, CI Mockridge, ...
Cancer cell 27 (1), 138-148, 2015
Mandates: Cancer Research UK
Obinutuzumab induces superior B-cell cytotoxicity to rituximab in rheumatoid arthritis and systemic lupus erythematosus patient samples
V Reddy, C Klein, DA Isenberg, MJ Glennie, G Cambridge, MS Cragg, ...
Rheumatology 56 (7), 1227-1237, 2017
Mandates: Versus Arthritis, UK
Eradication of lymphoma by CD8 T cells following anti-CD40 monoclonal antibody therapy is critically dependent on CD27 costimulation
RR French, VY Taraban, GR Crowther, TF Rowley, JC Gray, PW Johnson, ...
Blood, The Journal of the American Society of Hematology 109 (11), 4810-4815, 2007
Mandates: Cancer Research UK
Antagonistic human FcγRIIB (CD32B) antibodies have anti-tumor activity and overcome resistance to antibody therapy in vivo
A Roghanian, I Teige, L Mårtensson, KL Cox, M Kovacek, A Ljungars, ...
Cancer cell 27 (4), 473-488, 2015
Mandates: Cancer Research UK, UK Medical Research Council
Antibodies to costimulatory receptor 4-1BB enhance anti-tumor immunity via T regulatory cell depletion and promotion of CD8 T cell effector function
SL Buchan, L Dou, M Remer, SG Booth, SN Dunn, C Lai, M Semmrich, ...
Immunity 49 (5), 958-970. e7, 2018
Mandates: Blood Cancer UK, Cancer Research UK, Wellcome Trust
Influence of immunoglobulin isotype on therapeutic antibody function
SA Beers, MJ Glennie, AL White
Blood, The Journal of the American Society of Hematology 127 (9), 1097-1101, 2016
Mandates: Blood Cancer UK, Cancer Research UK
Control of established melanoma by CD27 stimulation is associated with enhanced effector function and persistence, and reduced PD-1 expression of tumor infiltrating CD8+ T cells
DJ Roberts, NA Franklin, LM Kingeter, H Yagita, AL Tutt, MJ Glennie, ...
Journal of immunotherapy 33 (8), 769-779, 2010
Mandates: US National Institutes of Health
Clinical and biological effects of an agonist anti-CD40 antibody: a Cancer Research UK phase I study
P Johnson, R Challis, F Chowdhury, Y Gao, M Harvey, T Geldart, P Kerr, ...
Clinical Cancer Research 21 (6), 1321-1328, 2015
Mandates: Cancer Research UK
Antibody distance from the cell membrane regulates antibody effector mechanisms
KLS Cleary, HT Chan, S James, MJ Glennie, MS Cragg
The Journal of Immunology 198 (10), 3999-4011, 2017
Mandates: UK Biotechnology and Biological Sciences Research Council, Blood Cancer UK …
Complex interplay between epitope specificity and isotype dictates the biological activity of anti-human CD40 antibodies
X Yu, HTC Chan, CM Orr, O Dadas, SG Booth, LN Dahal, CA Penfold, ...
Cancer cell 33 (4), 664-675. e4, 2018
Mandates: Cancer Research UK
Publication and funding information is determined automatically by a computer program